ST. JUDE ACQUISITION OF SIEMENS PACESETTER GETS INVESTOR BLESSING
This article was originally published in The Gray Sheet
Executive Summary
ST. JUDE ACQUISITION OF SIEMENS PACESETTER GETS INVESTOR BLESSING as the stock gains 5-3/4 to 32-1/2 in June, making it both the leading point and percentage gainer on "The Gray Sheet" Index of NASDAQ-traded stocks. The issue realized most of its 21.5% gain following the June 28 announcement that St. Jude had entered a definitive agreement to purchase Siemens' worldwide cardiac rhythm management business for approximately $500 mil. ("The Gray Sheet" July 4, p. 5).
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.